Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of CancerElise A. Olsen, Eric C. Vonderheid, Sean Whittaker et al.|Journal of Clinical Oncology|2011Cited by 657
Non-Hodgkin’s LymphomasAndrew D. Zelenetz, Furhan Yunus, Jeremy S. Abramson et al.|Journal of the National Comprehensive Cancer Network|2010Cited by 329
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTCElise A. Olsen, Julia Scarisbrick, Pablo L. Ortiz‐Romero et al.|Blood|2021Cited by 170
NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016Steven M. Horwitz, Pierluigi Porcu, Andrew D. Zelenetz et al.|Journal of the National Comprehensive Cancer Network|2016Cited by 141
Diffuse Large B-Cell Lymphoma Version 1.2016Andrew D. Zelenetz, Hema Sundar, Leo I. Gordon et al.|Journal of the National Comprehensive Cancer Network|2016Cited by 87